{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T03:56:58Z","timestamp":1769745418173,"version":"3.49.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","heartlungcirc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart, Lung and Circulation"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.hlc.2025.08.010","type":"journal-article","created":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T11:50:50Z","timestamp":1757677850000},"page":"1033-1040","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Heart Failure With Preserved Ejection Fraction in Patients With Obesity: A Growing Cardiometabolic Concern"],"prefix":"10.1016","volume":"34","author":[{"given":"Andrew P.","family":"Sindone","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter P.","family":"Abhayaratna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alicia","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa","family":"Leung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8805-370X","authenticated-orcid":false,"given":"Ingrid","family":"Hopper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3011-0836","authenticated-orcid":false,"given":"John","family":"Amerena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmine G.","family":"De Pasquale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Burdeniuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew J.S.","family":"Coats","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2271-578X","authenticated-orcid":false,"given":"John J.","family":"Atherton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.hlc.2025.08.010_bib1","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1186\/s12913-016-1748-0","article-title":"Current and projected burden of heart failure in the Australian adult population: a substantive but still ill-defined major health issue","volume":"16","author":"Chan","year":"2016","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.hlc.2025.08.010_bib2","doi-asserted-by":"crossref","first-page":"4497","DOI":"10.1002\/ehf2.13661","article-title":"Clinical characteristics of people with heart failure in Australian general practice: results from a retrospective cohort study","volume":"8","author":"Sindone","year":"2021","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.hlc.2025.08.010_bib3","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s12872-016-0208-4","article-title":"Prevalence of heart failure in Australia: a systematic review","volume":"16","author":"Sahle","year":"2016","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.hlc.2025.08.010_bib4","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1016\/S0140-6736(12)61729-2","article-title":"Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990\u20132010: a systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"Vos","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.hlc.2025.08.010_bib5","author":"Chen"},{"key":"10.1016\/j.hlc.2025.08.010_bib6","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1002\/ejhf.822","article-title":"Do patients have worse outcomes in heart failure than in cancer? A primary care-based cohort study with 10-year follow-up in Scotland","volume":"19","author":"Mamas","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.hlc.2025.08.010_bib7","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/j.cardfail.2023.07.006","article-title":"Heart failure epidemiology and outcomes statistics: a report of the Heart Failure Society of America","volume":"29","author":"Bozkurt","year":"2023","journal-title":"J Card Fail"},{"key":"10.1016\/j.hlc.2025.08.010_bib8","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.15420\/cfr.2023.05","article-title":"Global public health burden of heart failure: an updated review","volume":"9","author":"Shahim","year":"2023","journal-title":"Card Fail Rev"},{"key":"10.1016\/j.hlc.2025.08.010_bib9","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.ijcard.2013.12.028","article-title":"The annual global economic burden of heart failure","volume":"171","author":"Cook","year":"2014","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.hlc.2025.08.010_bib10","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.hlc.2018.06.1042","article-title":"National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand: guidelines for the prevention, detection, and management of heart failure in Australia 2018","volume":"27","author":"Atherton","year":"2018","journal-title":"Heart Lung Circ"},{"key":"10.1016\/j.hlc.2025.08.010_bib11","doi-asserted-by":"crossref","first-page":"113.e1","DOI":"10.5694\/mja15.00801","article-title":"Acute heart failure admissions in New South Wales and the Australian Capital Territory: the NSW HF Snapshot Study","volume":"204","author":"Newton","year":"2016","journal-title":"Med J Aust"},{"key":"10.1016\/j.hlc.2025.08.010_bib12","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/nrcardio.2017.65","article-title":"Epidemiology of heart failure with preserved ejection fraction","volume":"14","author":"Dunlay","year":"2017","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.hlc.2025.08.010_bib13","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s12471-016-0810-1","article-title":"Understanding heart failure with preserved ejection fraction: where are we today?","volume":"24","author":"van Heerebeek","year":"2016","journal-title":"Neth Heart J"},{"key":"10.1016\/j.hlc.2025.08.010_bib14","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s11897-013-0155-7","article-title":"The emerging epidemic of heart failure with preserved ejection fraction","volume":"10","author":"Oktay","year":"2013","journal-title":"Curr Heart Fail Rep"},{"key":"10.1016\/j.hlc.2025.08.010_bib15","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1093\/cvr\/cvac013","article-title":"Global burden of heart failure: a comprehensive and updated review of epidemiology","volume":"118","author":"Savarese","year":"2023","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.hlc.2025.08.010_bib16","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/s41569-020-0363-2","article-title":"Evaluation and management of heart failure with preserved ejection fraction","volume":"17","author":"Borlaug","year":"2020","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.hlc.2025.08.010_bib17","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1002\/ehf2.15205","article-title":"State of precision medicine for heart failure with preserved ejection fraction in a new therapeutic age","volume":"12","author":"Rasalam","year":"2025","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.hlc.2025.08.010_bib18","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s11897-022-00582-x","article-title":"Defining the phenotypes for heart failure with preserved ejection fraction","volume":"19","author":"Rucker","year":"2022","journal-title":"Curr Heart Fail Rep"},{"key":"10.1016\/j.hlc.2025.08.010_bib19","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s12265-017-9756-y","article-title":"Precision medicine for heart failure with preserved ejection fraction: an overview","volume":"10","author":"Shah","year":"2017","journal-title":"J Cardiovasc Transl Res"},{"key":"10.1016\/j.hlc.2025.08.010_bib20","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1002\/ehf2.13969","article-title":"Phenotypes of heart failure with preserved ejection fraction and effect of spironolactone treatment","volume":"9","author":"Choy","year":"2022","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.hlc.2025.08.010_bib21","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jchf.2019.09.009","article-title":"Clinical phenogroups in heart failure with preserved ejection fraction: detailed phenotypes, prognosis, and response to spironolactone","volume":"8","author":"Cohen","year":"2020","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.hlc.2025.08.010_bib22","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1093\/eurheartj\/ehaf057","article-title":"Near-universal prevalence of central adiposity in heart failure with preserved ejection fraction: the Paragon-HF trial","volume":"46","author":"Peikert","year":"2025","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hlc.2025.08.010_bib24","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1001\/jamacardio.2018.0022","article-title":"Association of body mass index with lifetime risk of cardiovascular disease and compression of morbidity","volume":"3","author":"Khan","year":"2018","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.hlc.2025.08.010_bib25","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/1753-6405.12471","article-title":"Cancers in Australia in 2010 attributable to modifiable factors: summary and conclusions","volume":"39","author":"Whiteman","year":"2015","journal-title":"Aust N Z J Public Health"},{"key":"10.1016\/j.hlc.2025.08.010_bib26","article-title":"Diabetes mellitus and heart failure with preserved ejection fraction: role of obesity","volume":"12","author":"Dhore-Patil","year":"2021","journal-title":"Front Physiol"},{"key":"10.1016\/j.hlc.2025.08.010_bib27","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jacc.2016.05.019","article-title":"The HFpEF obesity phenotype: the elephant in the room","volume":"68","author":"Kitzman","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hlc.2025.08.010_bib28","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1002\/ehf2.14560","article-title":"Obesity, heart failure with preserved ejection fraction, and the role of glucagon-like peptide-1 receptor agonists","volume":"11","author":"Cimino","year":"2024","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.hlc.2025.08.010_bib29","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1161\/CIRCULATIONAHA.117.032474","article-title":"Leptin-aldosterone-neprilysin axis: identification of its distinctive role in the pathogenesis of the three phenotypes of heart failure in people with obesity","volume":"137","author":"Packer","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.hlc.2025.08.010_bib30","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1016\/j.mayocp.2023.07.008","article-title":"Obesity, cardiorenal comorbidities, and risk of hospitalization in patients with heart failure with preserved ejection fraction","volume":"98","author":"Morgen","year":"2023","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.hlc.2025.08.010_bib31","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1016\/j.jacc.2017.09.1111","article-title":"Abdominal obesity is associated with an increased risk of all-cause mortality in patients with HFpEF","volume":"70","author":"Tsujimoto","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hlc.2025.08.010_bib32","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hlc.2025.08.010_bib33","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1161\/CIRCULATIONAHA.119.041886","article-title":"Research priorities for heart failure with preserved ejection fraction: National Heart, Lung, and Blood Institute working group summary","volume":"141","author":"Shah","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.hlc.2025.08.010_bib34","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1183\/16000617.0081-2016","article-title":"Exertional dyspnoea in obesity","volume":"25","author":"Bernhardt","year":"2016","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.hlc.2025.08.010_bib35","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1161\/CIRCULATIONAHA.118.034646","article-title":"A simple, evidence-based approach to help guide diagnosis of heart failure with preserved ejection fraction","volume":"138","author":"Reddy","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.hlc.2025.08.010_bib36","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.1093\/eurheartj\/ehz641","article-title":"How to diagnose heart failure with preserved ejection fraction: the HFA-PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)","volume":"40","author":"Pieske","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hlc.2025.08.010_bib37","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0735-1097(00)01156-6","article-title":"Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care setting","volume":"37","author":"Dao","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hlc.2025.08.010_bib38","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1016\/j.jacc.2003.05.011","article-title":"Plasma amino-terminal pro-brain natriuretic peptide and accuracy of heart-failure diagnosis in primary care: a randomized, controlled trial","volume":"42","author":"Wright","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hlc.2025.08.010_bib39","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.ahj.2006.05.020","article-title":"Influence of history of heart failure on diagnostic performance and utility of B-type natriuretic peptide testing for acute dyspnea in the emergency department","volume":"152","author":"Chung","year":"2006","journal-title":"Am Heart J"},{"key":"10.1016\/j.hlc.2025.08.010_bib40","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.15420\/japsc.2022.42","article-title":"Asian pacific society of cardiology consensus statements on the diagnosis and management of chronic heart failure","volume":"2","author":"Sim","year":"2023","journal-title":"J Asian Pac Soc Cardiol"},{"key":"10.1016\/j.hlc.2025.08.010_bib41","first-page":"45","article-title":"Natriuretic peptides in the diagnosis of heart failure Improving clinical confidence and accuracy","volume":"25","author":"Sindone","year":"2024","journal-title":"Med Today"},{"key":"10.1016\/j.hlc.2025.08.010_bib42","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1161\/CIRCULATIONAHA.124.072156","article-title":"Evidence-based application of natriuretic peptides in the evaluation of chronic heart failure with preserved ejection fraction in the ambulatory outpatient setting","volume":"151","author":"Reddy","year":"2025","journal-title":"Circulation"},{"key":"10.1016\/j.hlc.2025.08.010_bib43","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.022930","article-title":"Pragmatic weight management program for patients with obesity and heart failure with preserved ejection fraction","volume":"10","author":"El Hajj","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.hlc.2025.08.010_bib44","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.jchf.2019.04.019","article-title":"Hemodynamic effects of weight loss in obesity: a systematic review and meta-analysis","volume":"7","author":"Reddy","year":"2019","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.hlc.2025.08.010_bib45","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1093\/eurheartj\/ehac071","article-title":"Bariatric surgery and cardiovascular disease: a systematic review and meta-analysis","volume":"43","author":"van Veldhuisen","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hlc.2025.08.010_bib46","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/oby.22038","article-title":"Bariatric surgery-induced cardiac and lipidomic changes in obesity-related heart failure with preserved ejection fraction","volume":"26","author":"Mikhalkova","year":"2018","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.hlc.2025.08.010_bib47","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJMoa1908655","article-title":"Angiotensin-neprilysin inhibition in heart failure with preserved ejection fraction","volume":"381","author":"Solomon","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hlc.2025.08.010_bib48","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1161\/CIRCULATIONAHA.119.044586","article-title":"Sacubitril\/Valsartan across the spectrum of ejection fraction in heart failure","volume":"141","author":"Solomon","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.hlc.2025.08.010_bib49","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMoa2107038","article-title":"Empagliflozin in heart failure with a preserved ejection fraction","volume":"385","author":"Anker","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hlc.2025.08.010_bib50","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1056\/NEJMoa2206286","article-title":"Dapagliflozin in heart failure with mildly reduced or preserved ejection fraction","volume":"387","author":"Solomon","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hlc.2025.08.010_bib51","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1002\/ejhf.3221","article-title":"Body mass index and cardiorenal outcomes in the EMPEROR-Preserved trial: principal findings and meta-analysis with the DELIVER trial","volume":"26","author":"Sattar","year":"2024","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.hlc.2025.08.010_bib52","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1056\/NEJMoa2407107","article-title":"Finerenone in heart failure with mildly reduced or preserved ejection fraction","volume":"391","author":"Solomon","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hlc.2025.08.010_bib53","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jacc.2024.10.111","article-title":"Finerenone, obesity, and heart failure with mildly reduced\/preserved ejection fraction: prespecified analysis of FINEARTS-HF","volume":"85","author":"Butt","year":"2025","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hlc.2025.08.010_bib54","first-page":"35","article-title":"iCARDIO alliance global implementation guidelines on heart failure 2025","volume":"36","author":"Chopra","year":"2025","journal-title":"Cardiovasc J Afr"},{"key":"10.1016\/j.hlc.2025.08.010_bib55","doi-asserted-by":"crossref","first-page":"213","DOI":"10.12997\/jla.2023.12.3.213","article-title":"The cardiovascular effect of tirzepatide: a glucagon-like Peptide-1 and glucose-dependent insulinotropic polypeptide dual agonist","volume":"12","author":"Cho","year":"2023","journal-title":"J Lipid Atheroscler"},{"key":"10.1016\/j.hlc.2025.08.010_bib56","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1210\/clinem\/dgab722","article-title":"Effects of tirzepatide, a dual GIP and GLP-1 RA, on lipid and metabolite profiles in subjects with type 2 diabetes","volume":"107","author":"Pirro","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.hlc.2025.08.010_bib57","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1056\/NEJMoa2306963","article-title":"Semaglutide in patients with heart failure with preserved ejection fraction and obesity","volume":"389","author":"Kosiborod","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hlc.2025.08.010_bib58","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1056\/NEJMoa2313917","article-title":"Semaglutide in patients with obesity-related heart failure and type 2 diabetes","volume":"390","author":"Kosiborod","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hlc.2025.08.010_bib59","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1016\/S0140-6736(24)00469-0","article-title":"Semaglutide versus placebo in people with obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF and STEP-HFpEF DM randomised trials","volume":"403","author":"Butler","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.hlc.2025.08.010_bib60","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/S0140-6736(24)01643-X","article-title":"Semaglutide versus placebo in patients with heart failure and mildly reduced or preserved ejection fraction: a pooled analysis of the SELECT, FLOW, STEP-HFpEF, and STEP-HFpEF DM randomised trials","volume":"404","author":"Kosiborod","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.hlc.2025.08.010_bib61","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1056\/NEJMoa2410027","article-title":"Tirzepatide for heart failure with preserved ejection fraction and obesity","volume":"392","author":"Packer","year":"2025","journal-title":"N Engl J Med"}],"container-title":["Heart, Lung and Circulation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1443950625016014?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1443950625016014?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T23:31:03Z","timestamp":1759793463000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1443950625016014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":60,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S1443950625016014"],"URL":"https:\/\/doi.org\/10.1016\/j.hlc.2025.08.010","relation":{},"ISSN":["1443-9506"],"issn-type":[{"value":"1443-9506","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Heart Failure With Preserved Ejection Fraction in Patients With Obesity: A Growing Cardiometabolic Concern","name":"articletitle","label":"Article Title"},{"value":"Heart, Lung and Circulation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hlc.2025.08.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier B.V. on behalf of Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ).","name":"copyright","label":"Copyright"}]}}